Trial Profile
Autologous TLPLDC vaccine (tumor lysate, particle loaded, dendritic cells): a single-arm open-label trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Tumour lysate particle-loaded dendritic cell vaccine Elios Therapeutics (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 03 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Mar 2016 New trial record